Sotera Health Co.

NAS: SHC

GO
/marketstate/country/us

Market open

 --Real time quotes

May 20, 2022, 12:45 p.m.

SHC
/zigman2/quotes/222596028/composite

$

19.68

Change

-0.08 -0.43%

Volume

Volume 133,182

Real time quotes

/zigman2/quotes/222596028/composite

Previous close

$ 19.76

$ 19.68

Change

-0.08 -0.43%

Day low

Day high

$19.59

$20.00

Open

52 week low

52 week high

$18.31

$27.38

Open

Dave Anthony Donnini

Currently, Dave Anthony Donnini is Chairman for Vivid Seats, Inc. and Chairman for Vivid Seats, Inc. Mr. Donnini is also on the board of 10 other companies.

In the past Mr. Donnini held the position of Associate Consultant at Bain & Co., Inc., Director at STANLEY Convergent Security Solutions, Inc., Director at Boomerang Media LLC, Director at Prime Succession, Inc., Director at Polypore, Inc., Director at Gensar Holdings, Inc. and Director at Cambridge Protection Industries LLC.

Dave Anthony Donnini received an undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.

Transactions

Date Shares Transaction Value
05/28/2021 9,336   Award at $0 per share. 0

Officers and Executives

Mr. Michael B. Petras
Chairman & Chief Executive Officer
Mr. Scott J. Leffler
Chief Financial Officer & Treasurer
Mr. Robert G. Hauzie
Chief Information Officer
Mr. Michael P. Rutz
President-Sterigenics
Mr. Kurt M. Roth
Senior VP-Corporate Development & Strategy
Ms. Kristin A. Gibbs
Chief Marketing Officer & Media Contact
Ms. Sally J. Curley
Head-Investor Relations
Ms. Sally Turner
Chief Human Resources Officer
Mr. Terrence G. Hammons
Secretary, Senior Vice President & General Counsel
Mr. Sean Laurence Cunningham
Independent Director
Mr. Dave Anthony Donnini
Independent Director
Ms. Stephanie Geveda
Independent Director
Ms. Ann R. Klee
Independent Director
Mr. Dean Spyro Mihas
Independent Director
Mr. James C. Neary
Independent Director
Mr. Ruoxi Chen
Independent Director
Mr. Vincent Kevin Petrella
Independent Director
Dr. David E. Wheadon
Independent Director
Link to MarketWatch's Slice.